NCT07128485

Brief Summary

This Type 1 hybrid effectiveness-implementation randomized controlled trial, Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdose rates. It is supported by and included in the HEAL Initiative. This study would be the first national, fully remote trial to assess the impact of fentanyl test strips on overdose outcomes, using a novel 2x2 design crossing fentanyl test strip distribution and education to determine which approach most significantly reduces overdose rates while minimizing costs. This research will inform scalability around mail-based fentanyl test strip distribution and education programs to address the nation's opioid overdose crisis.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started Sep 2026

Geographic Reach
1 country

2 active sites

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 13, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 19, 2025

Completed
1 year until next milestone

Study Start

First participant enrolled

September 1, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

1 year

First QC Date

August 13, 2025

Last Update Submit

April 7, 2026

Conditions

Keywords

overdose preventionfentanyl test stripsfentanylopioid use disorderstimulant use disorderaccidental overdose

Outcome Measures

Primary Outcomes (1)

  • Overdose

    Includes both self-reported non-fatal overdose and fatal overdose as reported by the National Death Index.

    Baseline, 1 month, 3 months, 6 months

Secondary Outcomes (1)

  • Fentanyl test strip knowledge

    Baseline, 1 month, 3 months, 6 months

Other Outcomes (6)

  • Protective Behavioral Strategies

    Baseline, 1 month, 3 months, 6 months

  • Types of drugs tested with fentanyl test strips

    Baseline, 1 month, 3 months, 6 months

  • Number of fentanyl test strips used

    Baseline, 1 month, 2 months, 3 months, 4 months, 5 months, 6 months

  • +3 more other outcomes

Study Arms (4)

FDE

EXPERIMENTAL

This arm receives both FTS distribution (FTS delivered to their residential address) and education (FDE), as well as a resource list for naloxone and additional FTS if desired.

Other: Fentanyl test stripsBehavioral: Fentanyl test strip education

E

EXPERIMENTAL

The Education only (E) arm receives FTS education as well as a resource list for obtaining naloxone and FTS.

Behavioral: Fentanyl test strip education

FD

EXPERIMENTAL

The FTS distribution only (FDE) arm receives FTS delivered to their residential address as well as a resource list for obtaining naloxone and additional FTS, if desired.

Other: Fentanyl test strips

R

NO INTERVENTION

The referral only (R) arm receives a resource list for obtaining naloxone and FTS.

Interventions

Fentanyl test strips (FTS) are small strips of paper that can detect the presence of fentanyl in illicit drugs.

FDFDE

Developed in the R61 phase, the educational intervention will provide participants with knowledge about how to correctly use fentanyl strips.

EFDE

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old
  • English-speaking and reading
  • Report using illicit opioids and/or stimulants (including counterfeit pills) within the past 3 months per the ASSIST
  • Able and willing to provide informed consent
  • Reside in any of the US states where fentanyl test strips are legal with no plans to move out of state for at least 12 months
  • Reside in any of the US states where FTS are legal with no plans to move out of state for at least 12 months
  • Be able and willing to provide the names and contact information of three close contacts to reach if the participant cannot be reached

You may not qualify if:

  • Living in a restricted environment (e.g., prison)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

University of Alabama at Birmingham

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

Opioid-Related Disorders

Condition Hierarchy (Ancestors)

Narcotic-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Central Study Contacts

Emma S Kay, PhD, MSW

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Model Details: Using a 2x2 design, there will be four study arms. All arms will be given a resource list on where to obtain naloxone and fentanyl test strips (FTS), while other arms will additionally receive mail-distributed FTS, FTS education, or both. These 4 groups include: FTS distribution + education (FDE), FTS education (E), FTS distribution only (FD), and a control group (referral only).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

August 13, 2025

First Posted

August 19, 2025

Study Start (Estimated)

September 1, 2026

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations